OSL oncosil medical ltd

Ann: Non-renounceable Rights Issue Offer Prospectus, page-82

  1. 8,257 Posts.
    lightbulb Created with Sketch. 3241
    Based on what exactly?

    They burn through on average 10 million a year, Losing about $2.5 mill a quarter. This capraise, if it is even fully accepted which is very unlikely, is only buying them another year. Whats going to be different in this next year?

    They did a capraise for $20 mill in 2020, then did another one for $10 mill in April last year, already blown through it , doing another one now for $10 mill, but somehow this is the last one?

    All those raisings are over 70% down in just a couple of years.

    What you have here is a company that is good for management who can keep paying themselves, bad for shareholders who get no return, you need to be objective here to the reality of whats happening.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.070(5.69%)
Mkt cap ! $16.49M
Open High Low Value Volume
$1.25 $1.25 $1.11 $72.36K 60.96K

Buyers (Bids)

No. Vol. Price($)
1 9286 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.18 412 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.